This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

National Research Corporation Announces First Quarter 2014 Results

Stocks in this article: NRCIA NRCIB

LINCOLN, Neb., May 6, 2014 (GLOBE NEWSWIRE) -- National Research Corporation (Nasdaq:NRCIA) (Nasdaq:NRCIB) today announced results for the first quarter of 2014.

  • Net New Sales $3.3 million
  • Total Contract Value $99.4 million
  • Revenue up 5% to $26.0 million
  • Net Income of $5.5 million, up 22%

Remarking on company performance, Michael D. Hays, chief executive officer of National Research said, "Even given our planned investment in Customer Connect and revenue at 98% of plan, the company's combined earnings per share grew 22%."

Revenue for the quarter ended March 31, 2014, was $26.0 million, compared to $24.9 million for the same quarter in 2013. Net income for the quarter ended March 31, 2014, was $5.5 million, compared to $4.5 million for the quarter ended March 31, 2013. Diluted earnings per share increased to $0.13 for Class A shares and $0.77 for Class B shares for the quarter ended March 31, 2014, from diluted earnings per share of $0.11 for Class A shares and $0.64 for Class B shares for the quarter ended March 31, 2013. Combined diluted earnings per share (a non-GAAP measure) increased to $0.22 for the quarter ended March 31, 2014, from $0.18 for the first quarter of 2013.

Regarding first quarter performance, Kevin Karas, chief financial officer of National Research, said, "We achieved significant improvement in our net income margin, growing from 18% in the first quarter of 2013 to 21% in 2014. From a revenue standpoint, we continue to see strong double-digit growth in our Acute Care Patient Experience (14%), Market Insights (14%) and Connect (42%) offerings."

A listen-only simulcast of the National Research 2014 first quarter conference call will be available online at on May 7, 2014, beginning at 11:00 a.m. Eastern time. The online replay will follow approximately one hour later and continue for 30 days.

For more than 33 years, National Research Corporation has been at the forefront of patient-centered care, helping healthcare providers measure and improve quality and services through analytics that offer a rich understanding of customers' experiences, preferences, risks and behaviors across the healthcare continuum.        

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,793.68 +15.53 0.09%
S&P 500 2,066.68 +5.45 0.26%
NASDAQ 4,759.4920 +11.0960 0.23%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs